Volume 28, Number 8—August 2022
CME ACTIVITY - Synopsis
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies1
Figure 1
![Study selection flowchart for a systematic review of published and unpublished studies for evidence for ribavirin treatment of Lassa fever. ITCRP, World Health Organization International Clinical Trials Registry Platform; PACTR, Pan African Clinical Trial Registry.](/eid/images/21-1787-F1.jpg)
Figure 1. Study selection flowchart for a systematic review of published and unpublished studies for evidence for ribavirin treatment of Lassa fever. ITCRP, World Health Organization International Clinical Trials Registry Platform; PACTR, Pan African Clinical Trial Registry.
1Preliminary results from this study were presented at the World Health Organization Emergency Program on December 21, 2019.
Page created: June 14, 2022
Page updated: July 24, 2022
Page reviewed: July 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.